Splenectomy for hematological disease:an analysis of 64 casesLIU Ji，SUN Bei，JIANG Hongchi，et al.Department of Hepatopancreato Biliary Surgery，the First Affiliated Hospital of Harbin Medical University，Harbin 150001,China Corresponding author：SUNBei， Email：sunbei70@tom.com AbstractObjectiveTo investigate the therapeutic efficacy,indications and postoperative complications of splenectomy in patients with hematological diseases.MethodsThe clinical data of 64 patients suffering from hematological diseases admitted between January 1996 and January 2008 at the First Affiliated Hospital of Harbin Medical University were analyzed retrospectively.The therapeutic efficacy,the postoperative complications and some preventive measures were discussed.ResultsSplenectomy could exert significant therapeutic effects on the diseases of idiopathic thrombocytopenic purpura (ITP),hereditary spherocytosis (HS),autoimmune hemolytic anemia (AHA) and polycythemia vera (PV).The effective rates were 84%,100%,60% and 50% respectively.But the treatment effects on the others diseases such as nonHodgkin′s lymphoma (NHL),myelofibrosis,chronic myelogenous leukemia were below the mark.ConclusionSplenectomy is effective on the benign hematological diseases whenever nonsurgical management is invalid.However,the malignant hematological diseases treated by splenectomy need to be choosed carefully.